EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Takeover/Mergers Acquisitions
Contact for investors and press Sebastian Frericks Head of Group Finance Investor Relations Tel.: +49 3641 220-116 E-Mail: [email protected]
End of Inside Information
15-Dec-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Carl Zeiss Meditec AG |
Göschwitzer Str. 51-52 | |
07745 Jena, Germany | |
Germany | |
Phone: | +49 (0)3641 220-0 |
Fax: | +49 (0)3641 220-112 |
E-mail: | [email protected] |
Internet: | www.zeiss.de/meditec-ag/ir |
ISIN: | DE0005313704 |
WKN: | 531370 |
Indices: | MDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1798059 |
End of Announcement | EQS News Service |
|
1798059 15-Dec-2023 CET/CEST
Carl Zeiss Meditec AG Stock
Based on 2 Buy predictions and 1 Sell predictions the sentiment towards Carl Zeiss Meditec AG is rather balanced.
As a result the target price of 122 € shows a very positive potential of 95.04% compared to the current price of 62.55 € for Carl Zeiss Meditec AG.